NF-κB-responsive miR-155 induces functional impairment of vascular smooth muscle cells by downregulating soluble guanylyl cyclase
Open Access
- 15 February 2019
- journal article
- research article
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 51 (2) , 1-12
Abstract
Vascular smooth muscle cells (VSMCs) play an important role in maintaining vascular function. Inflammation-mediated VSMC dysfunction leads to atherosclerotic intimal hyperplasia and preeclamptic hypertension; however, the underlying mechanisms are not clearly understood. We analyzed the expression levels of microRNA-155 (miR-155) in cultured VSMCs, mouse vessels, and clinical specimens and then assessed its role in VSMC function. Treatment with tumor necrosis factor-α (TNF-α) elevated miR-155 biogenesis in cultured VSMCs and vessel segments, which was prevented by NF-κB inhibition. MiR-155 expression was also increased in high-fat diet-fed ApoE−/− mice and in patients with atherosclerosis and preeclampsia. The miR-155 levels were inversely correlated with soluble guanylyl cyclase β1 (sGCβ1) expression and nitric oxide (NO)-dependent cGMP production through targeting the sGCβ1 transcript. TNF-α-induced miR-155 caused VSMC phenotypic switching, which was confirmed by the downregulation of VSMC-specific marker genes, suppression of cell proliferation and migration, alterations in cell morphology, and NO-induced vasorelaxation. These events were mitigated by miR-155 inhibition. Moreover, TNF-α did not cause VSMC phenotypic modulation and limit NO-induced vasodilation in aortic vessels of miR-155−/− mice. These findings suggest that NF-κB-induced miR-155 impairs the VSMC contractile phenotype and NO-mediated vasorelaxation by downregulating sGCβ1 expression. These data suggest that NF-κB-responsive miR-155 is a novel negative regulator of VSMC functions by impairing the sGC/cGMP pathway, which is essential for maintaining the VSMC contractile phenotype and vasorelaxation, offering a new therapeutic target for the treatment of atherosclerosis and preeclampsia.Keywords
Funding Information
- National Research Foundation of Korea
This publication has 50 references indexed in Scilit:
- Smooth Muscle–Selective Inhibition of Nuclear Factor‐κB Attenuates Smooth Muscle Phenotypic Switching and Neointima Formation Following Vascular InjuryJournal of the American Heart Association, 2013
- Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental AtherosclerosisThe American Journal of Pathology, 2013
- MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophagesJournal of Clinical Investigation, 2012
- Smooth muscle cell phenotypic switching in atherosclerosisCardiovascular Research, 2012
- Activation of NF-κB in Placentas of Women with PreeclampsiaHypertension in Pregnancy, 2012
- A nitric oxide/cysteine interaction mediates the activation of soluble guanylate cyclaseProceedings of the National Academy of Sciences, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Trophoblasts Reduce the Vascular Smooth Muscle Cell Proatherogenic ResponseHypertension, 2008
- Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclaseProceedings of the National Academy of Sciences, 2007
- YC-1-Mediated Vascular Protection through Inhibition of Smooth Muscle Cell Proliferation and Platelet FunctionBiochemical and Biophysical Research Communications, 2002